Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-08-17

Clinical Trial Update: Evaluation of the HekaHeart Platform in Medication Management for Heart Failure Patients

View source ↗

Summary

This clinical trial registry entry indicates that Yale University's study evaluating the HekaHeart Platform for medication management in heart failure with redu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: Heart Failure With Reduced Ejection Fraction | Status: WITHDRAWN